-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Reiterates Buy on Neumora Therapeutics, Maintains $5 Price Target

Benzinga·05/13/2025 13:44:48
Listen to the news
Needham analyst Ami Fadia reiterates Neumora Therapeutics (NASDAQ:NMRA) with a Buy and maintains $5 price target.